Cartesian Therapeutics In...

NASDAQ: RNAC · Real-Time Price · USD
11.33
-0.10 (-0.87%)
At close: Aug 15, 2025, 3:59 PM
11.80
4.15%
After-hours: Aug 15, 2025, 06:53 PM EDT

Cartesian Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
15.89M -17.71M -10.25M -24.18M 13.84M -56.82M -177.66M -9M -11.39M -21.66M 5.89M -7.89M 8.6M 28.78M 12.24M -17.89M 4.57M -24.6M
Depreciation & Amortization
589K 1.16M 486K 300K 196K 183K 272K 189K 176K 206K 607K 539K 498K 644K 323K 622K 582K 479K
Stock-Based Compensation
3.28M 2.51M 1.86M 1.7M 1.59M 1.43M 14.14M 2.32M 3.78M 2.28M n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
8.01M -8.01M 2.15M -1.49M -1.29M -10.21M -2.27M -976K -654K 9.16M -4.31M -14.41M -13.36M -28.54M -33.92M -13.41M -7.81M -5.98M
Other Non-Cash Items
-44.36M -1.98M -5.95M 10.07M 2.01M 45.66M 18.78M 358K 561K 814K -7.36M -6.32M 26.11M -17.02M -1.54M 193K -1.09M 20.85M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 125.09M -3.05M -6.34M 4M n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
7.08M -7.08M 6.85M 25.81M -32.08M -6.37M -3.91M -34K 3.31M 5.6M -7.04M 2.35M -29.92M -25.76M -37.88M 5M -8.37M -6.94M
Operating Cash Flow
-17.52M -23.11M -7M 13.69M -14.45M -15.92M -23.29M -9.21M -9.89M -8.77M -11.85M 4.35M -12.27M -11.86M -31.46M -10.75M -6.04M -12.13M
Capital Expenditures
-2.6M -1.07M -705K -6.2M -1.59M -602K -64K n/a -12K -130K -211K -436K -99K -455K -278K -164K -618K -25K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 6.56M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -33.5M n/a n/a n/a -8.04M -2M -22.42M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a 28.25M 5.7M 4M n/a 10M 10M 6.4M n/a n/a
Other Investing Acitivies
n/a n/a 351K n/a n/a n/a 6.56M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-2.6M -1.07M -354K -6.2M -1.59M -602K 6.5M n/a -12K 28.12M 5.49M -29.94M -99K 9.54M 9.72M -1.8M -2.62M -22.45M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a -24.87M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
60K -8.03M 783K 124.49M 120K 3.03M 20.25M n/a -2.59M 149K 110K 197K n/a 38K 104K 91K 428K 316K
Financial Cash Flow
60K -8.03M 783K 124.49M 120K 43.03M 14.08M -24.79M -2.59M 149K n/a 612K 36.88M 1.73M 21.16M 1.45M 8.98M 21.31M
Net Cash Flow
-20.04M -32.18M -6.59M 131.97M -15.9M 26.51M -2.69M -34.02M -12.52M 19.49M -6.12M -25.21M 24.62M -620K -588K -11.1M 326K -13.27M
Free Cash Flow
-20.12M -24.18M -7.71M 7.49M -16.03M -16.52M -23.35M -9.21M -9.91M -8.89M -12.06M 3.92M -12.37M -12.32M -31.74M -10.91M -6.66M -12.16M